HARRIS TODD (Chief Executive Officer) sold 4.4% of their position (62.72K shares) of TYRA BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.71M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/22/2024ACC: 0000950170-24-116345
DirectorOfficer· Chief Executive Officer
Since Sep 2021
-62.72K
Net shares
Net seller
$1.71M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
62.72K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−43.64K
Price / share
$27.01
Trade value
$1.18M
% of position
3.1%
10/18/2024
1.42M→1.38M
Common Stock
Direct
Shares
−5.90K
Price / share
$27.32
Trade value
$161.08K
% of position
0.4%
10/21/2024
1.38M→1.37M
Common Stock
Direct
Shares
−13.19K
Price / share
$28.16
Trade value
$371.37K
% of position
1.0%
10/21/2024
1.37M→1.36M
Total
Net shares
−62.72K
Net value
-$1.71M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/18/2024 | S · Sale | −43.64K | $27.01 | $1.18M | 3.1% | 1.42M | 1.38M |
| Common Stock Direct | 10/21/2024 | S · Sale | −5.90K | $27.32 | $161.08K | 0.4% | 1.38M | 1.37M |
| Common Stock Direct | 10/21/2024 | S · Sale | −13.19K | $28.16 | $371.37K | 1.0% | 1.37M | 1.36M |
| Total | −62.72K | -$1.71M | ||||||
Derivative Transactions0
No derivative transactions reported